IL15 and ovarian carcinoma: On the other hand, NK cells are known to be increased in the tumor microenvironment in ovarian cancer and have early cytolytic activity on cancer cells, and several therapies have been tested in clinical trials to recruit NK cells in ovarian cancer using IL-15 and IL-2 with limited success [24].